An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these accounts directly for source information, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Experts Voice Worries
Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.
Some experts said the demand for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to fines, legal action or prison.
Platform Reaction and Content Elimination
According to the social media company, the service has taken down problematic material and banned associated keywords and query recommendations. The organization said it was committed to keeping the platform safe and allocating resources in enhancing compliance measures.
Online Trading Activities
Investigations also found groups with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, populated with photos of weight loss, positive testimonials and step-by-step guides for preparing or injecting at home.
After moments of entering one community, a seller posted contact information, where the majority of purchases occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.
Item Information and Pricing
Within these groups, posts display dark colored packages with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how much time a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram said it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has already seen individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may subject users to possibly serious medical dangers”.
